MedPath

Developing and Piloting an Online, Self-help Intervention (STAGE) for Anxiety

Not Applicable
Completed
Conditions
Anxiety
Interventions
Behavioral: STAGE training for anxiety
Registration Number
NCT04117906
Lead Sponsor
Canterbury Christ Church University
Brief Summary

This study pilots a novel, brief, online, self-help training course for anxiety management, aimed at adults experiencing moderate to moderately-severe anxiety.

Detailed Description

This study is a pilot randomised controlled trial (RCT) comparing a brief, online self-help, anxiety management training course ('STAGE') with a wait-list control. A battery of self-report measures will be administered online at baseline (week 0), post-intervention (week 3) and at follow-up (week 5).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
77
Inclusion Criteria
  • having a score, at baseline, on the Generalised Anxiety Disorder 7 (GAD-7) scale of between 8 and 15, inclusive;
  • having regular internet access;
  • being based in the UK.
Exclusion Criteria
  • significant risk issues in the last year;
  • currently receiving another psychological intervention, whether it be self-help or face-to-face;
  • having recently (within the last six months) completed a psychological intervention.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
STAGE courseSTAGE training for anxiety-
Primary Outcome Measures
NameTimeMethod
Change from baseline (week 0) at post-intervention (week 3) on the Generalised Anxiety Disorder 7 (GAD-7) scale.Post-intervention (3 weeks after baseline).

The Generalised Anxiety Disorder 7 (GAD-7) scale is a self-report measure of general anxiety, producing a total score between 0 and 21, with higher scores indicating greater levels of general anxiety.

Secondary Outcome Measures
NameTimeMethod
Change from baseline (week 0) at follow-up (week 5) on the Generalised Anxiety Disorder 7 (GAD-7) scale.Follow-up (5 weeks after baseline).

As described above

Change from baseline (week 0) at follow-up (week 5) on the Patient Health Questionnaire 9 (PHQ-9).Follow-up (5 weeks after baseline).

As described above

Change from baseline (week 0) at follow-up (week 5) on the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS).Follow-up (5 weeks after baseline).

As described above

Change from baseline (week 0) at post-intervention (week 3) on the Experience Questionnaire (EQ).Post-intervention (3 weeks after baseline).

The Experience Questionnaire (EQ) is a self-report measure of decentering, producing a total score between 20 and 100, with higher scores indicating greater levels of decentering.

Change from baseline (week 0) at post-intervention (week 3) on the Patient Health Questionnaire 9 (PHQ-9).Post-intervention (3 weeks after baseline).

The Patient Health Questionnaire 9 (PHQ-9) is a self-report measure of depression, producing a total score between 0 and 27, with higher scores indicating greater levels of depression.

Change from baseline (week 0) at post-intervention (week 3) on the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS).Post-intervention (3 weeks after baseline).

The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) is a self-report measure of mental wellbeing, producing a total score between 14 and 70, with higher scores indicating greater levels of mental wellbeing.

Change from baseline (week 0) at follow-up (week 5) on the Experience Questionnaire (EQ).Follow-up (5 weeks after baseline).

As described above

Change from baseline (week 0) at post-intervention (week 3) on the Putting into Perspective subscale of the Cognitive Emotion Regulation Questionnaire (CERQ).Post-intervention (3 weeks after baseline).

The Putting into Perspective subscale of the Cognitive Emotion Regulation Questionnaire (CERQ) is a self-report measure of perspective taking, producing a total score between 4 and 20.

Change from baseline (week 0) at follow-up (week 5) on the Putting into Perspective subscale of the Cognitive Emotion Regulation Questionnaire (CERQ).Follow-up (5 weeks after baseline).

As described above

Trial Locations

Locations (1)

Canterbury Christ Church University

🇬🇧

Tunbridge Wells, Kent, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath